LQDA Volume dana dhuwit perusahaan Liquidia Corp

liquidia.com - logo grafis emiten LQDA

Liquidia Corporation (LQDA) is recognized as an innovator in pulmonary hypertension therapy due to its unique drug delivery systems. The cash balance history demonstrates financial resilience, where the 0.40 metric determines the liquidity parameter status. Growth in cash flow from core products is complemented by a cohesive biotech culture, driven by stock options and the significance of their mission to combat rare lung pathologies.

LQDA - Aset likuid perusahaan Liquidia Corp ing rentang 04.07.2022 - 21.11.2026

Rincian metrik keuangan lan pasar Liquidia (LQDA)

Analisis fundamental perusahaan:LQDA Liquidia Corp
Sampel barang liquidia.com

For the pulmonary hypertension therapy biotech leader Liquidia Corporation (LQDA), maintaining liquid reserves is critical for funding the costly development of innovative inhalers. Analyzing the free cash flow chart, an investor assesses the company's ability to sustain operations without external borrowing, where excess funds ensure financial stability but may signal insufficiently aggressive reinvestment into business expansion.

Pesaing Liquidia Corporation (LQDA)

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|Sisa dhuwit perusahaan MENS|LGND: Dhuwit awis perusahaan|Sisa dhuwit perusahaan AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Dhuwit awis perusahaan|Alvotech - Sisa dhuwit perusahaan|Dana dhuwit perusahaan Galapagos N.V.|Dhuwit awis perusahaan ANI Pharmaceuticals, Inc. (ANIP)|Volume dana dhuwit perusahaan MNKD|AMPH (Amphastar Corp) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan pacira.com PCRX|SPRY - Dhuwit awis perusahaan|Theravance Biopharma, Inc. - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AQST (Aquestive Therapeutics, Inc.)|SCPH: Volume dana dhuwit perusahaan|Tectonic Therapeutic Inc. - Sisa dhuwit perusahaan|TNXP (Tonix Pharma) - Volume dana dhuwit perusahaan|SXTC: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan EPRX|BHST - Cadangan dhuwit perusahaan|eXoZymes - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan oramed.com ORMP|ENTX - Dana dhuwit perusahaan|Aset likuid perusahaan MindWalk Holdings HYFT|ABVC: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Cumberland Pharmaceuticals Inc.|Dana dhuwit perusahaan Quantum BioPharma Limited|FGEN: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan TELO|Rani Therapeutics Holdings, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Synergy CHC Corp. SNYR|Sisa dhuwit perusahaan RLYB|LEXX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Aptorum|Dhuwit awis perusahaan LYRA|Impact BioMedical Inc - Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan TNFA|YCBD - Cadangan dhuwit perusahaan|PainReform Ltd. - Dhuwit awis perusahaan|CYTO (Auris Medical) - Total volume dana dhuwit perusahaan|LIPO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan OPTN (OptiNose)|PIRS: Volume dana dhuwit perusahaan|Procaps Group S.A. (PROC) - Volume dana dhuwit perusahaan|PTPI (Petros Pharma) - Volume dana dhuwit perusahaan|QLI: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan